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Abstract 
Objectives: To outline the challenges and provide practical recommendations for recruiting inactive, statin-free older 
adults to facilitate feasible study designs. Data was obtained from a double-blind randomised-controlled clinical trial 
investigating the effects of acipimox versus placebo on muscle function and metabolism in older (65–75 years), inac-
tive, statin-free males. The initial recruitment target was 20 volunteers within 12 months (November 2016–November 
2017).
Results: Recruitment occurred via the Exeter 10,000 database containing 236 ‘eligible’ males, a Facebook campaign 
reaching > 8000 ≥ 65 years old males, 400 directly-addressed letters to ≥ 66 year old males, > 1500 flyers distributed 
within the community, > 40 emails to local community groups, 4 recruitment talks, 2 magazine adverts and 1 radio 
advert. Widespread recruitment efforts reaching > 120,000 people led to the recruitment of 20 volunteers (18 com-
pleted the clinical trial) within a 25-month timeframe, highlighting the challenge of the timely recruitment of inac-
tive, statin-free older adults for clinical trials. We recommend recruitment for future clinical trials should take a multi-
pronged approach from the outset, prioritising the use of volunteer databases, Facebook campaigns and delivering 
recruitment talks.
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Introduction
The age-related loss of muscle mass (sarcopenia) and 
strength (dynapenia) is associated with an increased risk 
of morbidity [12] and mortality [10], costing an estimated 
£5.7 billion annually (MRC 2012). Clinical trials (CTs) are 
therefore crucial in order to understand the mechanisms 
regulating age-related muscle decline, and to develop effi-
cacious therapeutic interventions for the maintenance of 
muscle health across the life-course.
Volunteer recruitment remains one of the biggest chal-
lenges for CTs [11], with three quarters of all CTs fail-
ing to meet recruitment deadlines [25] and/or requiring 
extensions [15]. This is particularly true for CTs looking 
to recruit healthy older adults due to a higher preva-
lence of pre-existing diseases [16] and polypharmacy 
(concurrent use of multiple medications) [13], mean-
ing that the recruitment criteria are often not met. This 
recruitment challenge is further exacerbated when rigor-
ous study-specific volunteer inclusion/exclusion criteria 
are applied, such as “physically inactive”, which is often 
seen as an essential control for robust studies of muscle 
function and metabolism. In addition, studies investigat-
ing the mechanistic basis of drug-based interventions 
often require invasive tissue sampling (e.g. blood and/or 
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muscle biopsies), both of which may deter older adults 
from volunteering [16, 22].
It is therefore prudent to disseminate the challenges 
and suggest practical recommendations for recruiting 
older adults to CTs that include comprehensive inclu-
sion/exclusion criteria so that an effective recruitment 
pipeline can be established amongst the ageing research 
community [21]. This paper reports the successes and 
challenges associated with the recruitment of 20 healthy 
older (65–75  years), inactive, statin-free males for a 
double-blind randomised CT involving exercise test-
ing, blood and muscle biopsy samples to investigate the 
effects of acipimox versus placebo on muscle function 
and metabolism.
Main text
Clinical trial study design
We aimed to recruit 20 healthy older males between 65 
and 75 years of age, over a 12-month period commencing 
November 2016. Volunteers were excluded if they: had 
a body mass index (BMI) < 19 or > 29  kg/m2, were tak-
ing chronic medication known to affect muscle metabo-
lism such as non-steroidal anti-inflammatory drugs 
(NSAIDs), were smokers, had active/past medical his-
tory (PMH) of cardiovascular, respiratory or metabolic 
disease, renal impairment, musculoskeletal injury, a pep-
tic ulcer, hypersensitivity to acipimox and/or vertigo. To 
control for activity status, a major confounder in exercise 
intervention trials, we excluded physically active indi-
viduals and thus required inactive volunteers, which we 
defined as performing no regular planned exercise, for at 
least the previous 12 months [8]. Finally, the study inter-
vention drug, acipimox, may increase the risk of myopa-
thy when administered concomitantly with a statin [9] (a 
commonly prescribed lipid-lowering HMG-CoA reduc-
tase inhibitor [19]). We therefore excluded individuals 
taking statins. This study involved five visits in total, each 
varying in length: (i) an eligibility screening visit (1  h), 
(ii) an exercise familiarisation session (2  h), and (iii–v) 
three experimental visits (5  h each). Across the study, 
each volunteer provided a total of 16 saliva samples, 22 
blood samples and 3 muscle biopsy samples (Bergström 
needle technique [2]). Each volunteer also completed 4 
maximal cardiorespiratory fitness tests  (VO2 max [6]), 4 
muscle power tests (Wingate [14]) and 4 physical func-
tion assessments (balance, gait speed and chair-rise abil-
ity [3]).
Recruitment methods and success rates
Potential volunteers were initially identified from the 
Exeter 10,000 database, which at the time of conducting 
searches (November 2016–September 2018) contained 
demographic and biochemical data from 9763 volunteers 
that were aged > 18 and living at a permanent address 
within 25 miles of Exeter (National Institute for Health 
Research Exeter Clinical Research Facility). Searching the 
database against the inclusion/exclusion criteria revealed 
236 as “eligible”, of which a total of 12 completed the CT 
(Fig.  1a). As 20 eligible volunteers were not identified 
through the Exeter 10,000 database, we employed addi-
tional recruitment methods that focused on increasing 
awareness of the CT amongst the general public. This 
recruitment drive took a multi-pronged approach to 
maximise reach to our target population and included: 
a Facebook campaign, demographically targeted (age 
and gender) postal invitations via the Royal Mail, flyers, 
presentations at local community groups, adverts in local 
magazines and local radio segments (Fig. 1a, b).
The Facebook campaign ran four times over a period of 
7 months (Additional file 1: Figure S1). The target audi-
ence specified in this campaign were: (i) ≥ 65 years old, 
(ii) male and (iii) living within 20 miles of Exeter. Having 
reached a minimum of > 8000 individuals within the tar-
get audience, a total of 71 responses were recorded with 
68 being excluded, 1 not completing the CT and 2 com-
pleting the CT (Table 1, Fig. 1a). Thus, this form of social 
media was an effective method to reach large numbers 
of the target population, which did lead to the success-
ful recruitment of eligible volunteers (Fig.  1b), although 
the majority were deemed ineligible due to the strict 
inclusion/exclusion criteria (i.e. physical activity levels/
statins).
Mailshots (400 to ≥ 66-year-old males, Additional file 1: 
Figure S2), flyers (> 1500 within the local area) and maga-
zine adverts (2 with a combined reach of > 22,000 homes) 
led to zero recruits and were thus deemed ineffective 
methods of recruitment. Personal email contact was 
made with 43 local community groups (e.g., local Bowls 
Club and University of the  3rd Age), of which 4 (17.4%) 
allowed researchers to present a short talk about the 
research project. From these 4 talks (to > 200 > 65-year-
old males), 11 potential volunteers made contact with 
2 completing the CT (Fig. 1a). Of the 2 volunteers from 
this route to complete the CT, 1 recommended a friend, 
who completed the CT. An additional 2 interested vol-
unteers reported hearing about the study through word 
of mouth, however 1 was ruled out due to NSAIDs ther-
apy and 1 did not respond to further communications. 
Thus, targeted talks and word-of-mouth were effective 
recruitment methods (Fig.  1b). A single radio segment 
mentioning the CT generated interest from 2 potential 
volunteers, 1 volunteer completed the CT, the other was 
excluded on the grounds of being too physically active.
To summarise, we approximate that our recruit-
ment efforts combined reached > 120,000 people, gen-
erating 221 responses (Fig.  2). Of these, 18 (8.1%) 
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volunteers completed the CT between November 
2016 and December 2018 of which 12 (66.7%) were 
recruited from the Exeter 10,000 database, 2 (11.1%) 
from Facebook, 2 (11.1%) from talks at local commu-
nity groups, 1 (5.6%) from word of mouth and 1 (5.6%) 
from a radio advertisement. Costs associated with each 
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Table 1 Breakdown of volunteer responses, ineligibility and recruitment rates to each Facebook campaign
Reach: number of people who saw the advert at least once during a single campaign (i.e. not cumulative over the campaigns). Impressions: the number of times that 
the advert was on screen. Frequency: the number of times that each person saw the advert
Month 
of campaign
Length 
of campaign 
(days)
Reach Impressions Frequency Responses Ineligible Reason Did 
not complete 
CT
Jan 18 29 3981 9019 2.27 28 28 9 (32.1%) Physical activity 0
7 (25%) Statins
3 (10.7%) Physical activity and statins
4 (14.3%) PMH
2 (7.1) No response
2 (7.1%) Declined to take part
1 (3.6%) Failed screening/familiarisa-
tion
Feb 18 26 5984 13,651 2.28 13 13 2 (15.4%) Physical activity 0
7 (53.9%) Statins
1 (7.7%) Physical activity and statins
1 (7.7%) Other
2 (15.6%) Failed screening/familiarisa-
tion
Apr 18 26 6740 15,046 2.23 13 11 2 (15.4%) Physical activity 1 (7.7%)
2 (15.4%) Statins
2 (15.4%) No response
4 (30.8%) Declined to take part
1 (7.7%) Other
Jul 18 4 8244 8418 1.02 17 16 1 (5.9%) Physical activity 0
7 (41.2%) Statins
5 (29.4%) No response
2 (11.8%) Declined to take part
1 (5.9%) Other
Fig. 2 Study recruitment flow chart. DNR did not respond, PA physical activity, PMH past medical history, S/F screening/familiarisation
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recruitment method can be found in Additional file 1: 
Table S1.
Discussion
This data shows that despite the use of multiple recruit-
ment methods that reached > 120,000 people and elic-
ited 221 responses from interested volunteers, the initial 
recruitment target of 20 within a 12-month period was 
not met. Instead, recruitment took 25 months, highlight-
ing the challenge of the timely recruitment of inactive, 
statin-free older adults to a randomised controlled CT.
Major barriers to recruitment herein were PMH, being 
too physically active and/or taking statins. This is not 
surprising as ageing per se increases the risk of cardio-
vascular-related disease [17], with almost all males over 
60 years of age qualifying for statin prescriptions under 
the National Institute for Healthcare Excellence (NICE) 
guidelines [24] and physical activity recommended as 
the most effective countermeasure [20, 23]. This obser-
vation highlights a key consideration in that our desired 
research volunteer population may not be representa-
tive of the ageing population. As such, follow-on studies, 
in which elucidating the underpinning mechanisms of 
the intervention is not the primary aim, are needed in a 
more representative ageing population (e.g. recreation-
ally active).
Although more lenient inclusion/exclusion criteria 
would likely result in substantially higher recruitment 
rates [26], for many CTs this is not possible due to seri-
ous safety concerns (e.g. relative contraindications) and 
potential impact on scientific rigour (e.g. introduction of 
major confounders into the study design). For example, in 
the current study statin prescription was excluded due to 
possible contraindications with the acipimox drug inter-
vention, where simultaneous consumption could lead to 
muscle toxicity [9]. Further, endurance and/or resistance 
exercise training improves muscle strength, muscle mass, 
mitochondrial metabolism and exercise capacity [7], so 
for this study it was critical for scientific robustness that 
inactive volunteers were recruited.
Practical recommendations
Of all of the recruitment methods used herein, the Exeter 
10,000 database provided the largest number of volun-
teers to complete the CT (Fig.  1a). However, searches of 
the database initially identified 236 people as “eligible”, 
where in actual fact > 30% of these were ineligible due to 
PMH. This suggests that the detail within the database (i.e. 
records of medications/PMH) may not be accurate, per-
haps due to changes in volunteers’ characteristics, which 
were not updated (Fig.  1b). Nonetheless, where possible 
we recommend that volunteer databases form the founda-
tions of recruitment drives for future CTs. However, the 
awareness and utility of such databases among CT teams is 
likely low since there is not a central resource (i.e. website) 
detailing the recruitment databases available within the 
UK. Further, access to these databases may be restricted 
if they are purpose-built, staffed and/or funded by certain 
research centres or organisations. Although larger-scale, 
regional or national databases would likely prove highly 
valuable for research volunteer recruitment, these may not 
be feasible due to data protection and ownership/manage-
ment considerations. We have, however, identified through 
personal communications with other researchers in the 
UK (i.e. the University of Nottingham Clinical Physiology 
research group at the Royal Derby Hospital) that the re-
recruitment of research volunteers via an annually updated 
internal database is an effective recruitment method for 
ageing research, and we therefore suggest that establishing 
internal recruitment databases may facilitate successful and 
timely volunteer recruitment, if these databases are man-
aged and updated appropriately.
Since we were unable to recruit all 20 volunteers through 
Exeter 10,000, we later employed alternative research 
strategies within Exeter (16% of population are > 65 years 
old), but also within surrounding rural areas due to the 
larger proportion of older adults (23–30% of population 
are > 65 years old) in these geographical regions (Office of 
National Statistics, [18]. Effective methods that did lead 
to volunteer recruitment were Facebook and the radio. 
Demographically targeted letters, flyers and magazine 
adverts were all ineffective for this study, similar to previ-
ous experience [1].
In summary, we highlight that stringent inclusion/exclu-
sion criteria present significant challenges to volunteer 
recruitment into CTs. In the absence of a completely effec-
tive ‘gold-standard’ recruitment method or pipeline, we 
provide suggestions for an experience-based framework 
for optimising recruitment strategies to benefit the wider 
CT community, and more specifically those involved in 
ageing research. This framework proposes a multipronged 
approach that utilises existing volunteer databases com-
bined with targeted social media and community group 
recruitment approaches undertaken simultaneously from 
the outset of a CT. We also wish to highlight that despite a 
growing body of CTs in the UK, a lack of public knowledge 
about where to find information on recruiting CTs is an 
additional challenge for recruitment (House of Commons 
[5], with a central website a potential solution to this.
Study limitations
• The challenges and successes of recruitment outlined 
herein are based on only one study conducted in the 
South West (UK) and it is possible that recruitment 
may be different based on geographical locations. For 
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example, the West Midlands have a greater percent-
age of inactive people (compared to the South West) 
[4] and thus, it may be easier to recruit inactive vol-
unteers within that region.
• The inability to identify overlap between people 
exposed to each recruitment strategy and the lack of 
precision in the estimation of reach may impact the 
effectiveness of each recruitment strategy.
• The recruitment strategies deemed as “effective” 
or “ineffective” herein may be relative to the small 
recruitment target (i.e. 20) and thus, may not be 
wholly suitable for CTs with larger recruitment tar-
gets.
Supplementary information
Supplementary information accompanies this paper at https ://doi.
org/10.1186/s1310 4-020-05017 -1.
Additional file 1: Table S1. Costs associated with each recruitment 
method. Figure S1. Facebook campaigns. Figure S2. Mailshot template.
Abbreviations
BMI: Body mass index; CT: Clinical trial; DNR: Did not respond; DTP: Declined to 
take part; ECG: Electrocardiogram; Fam: Familiarisation; NHS: National health 
service; NR: No response; NSAIDs: Nonsteroidal anti-inflammatory drugs; PA: 
Physical activity; PIS: Participant information sheet; PMH: Past medical history; 
S/F: Screening/familiarisation.
Acknowledgements
The authors would like to thank the volunteers for dedicating their time to 
completing the study. The authors would like to acknowledge the contribu-
tion of the admin, nurse, medical and research staff at the NIHR Exeter Clinical 
Research Facility for assisting volunteer recruitment, data/sample collection 
and medical examinations. This manuscript presents independent research 
funded by Dunhill Medical Trust supported by the National Institute for Health 
Research (NIHR) Exeter Clinical Research Facility. The views expressed are those 
of the author(s) and not necessarily those of the Dunhill Medical Trust, NHS, 
the NIHR or the Department of Health.
Authors’ contributions
CSD conceived the manuscript idea; CSD, AMS, TL and SAS performed volun-
teer recruitment; CSD, BEP, KS, PJA and TE wrote the manuscript. All authors 
read and approved the final manuscript.
Funding
This work was supported by a grant from Dunhill Medical Trust (R492/0516) 
and the NIHR Exeter CRF. CS Deane is a funded Medical Research Council 
Skills Development Fellow (MR/T026014/1). The funders had no role in study 
design, data analysis or outcome of the study.
Availability of data and materials
The dataset used and/or analysed for the current study are available from the 
corresponding author on reasonable request.
Ethics approval and consent to participate
All volunteers gave their informed written consent in accordance with the 
Declaration of Helsinki and following approval from and in accordance with 
the South West Research Ethics Committee (16/SW/0099). This study was 
registered as a clinical trial (NCT02792621).
Consent for publication
Not applicable.
Competing interests
The authors have declared that they have no competing interests.
Author details
1 Department of Sport and Health Sciences, College of Life and Environ-
mental Sciences, University of Exeter, St. Luke’s Campus, Exeter EX1 2LU, UK. 
2 Living Systems Institute, University of Exeter, Stocker Road, Exeter EX4 4QD, 
UK. 3 MRC-ARUK Centre for Musculoskeletal Ageing Research and National 
Institute of Health Research, Biomedical Research Centre, Division of Medicine 
and Graduate Entry Medicine, Royal Derby Hospital Centre, School of Medi-
cine, University of Nottingham, Derby DE22 3DT, UK. 4 National Institute 
for Health Research Exeter Clinical Research Facility, Research Innovation 
Learning and Development Building, Royal Devon and Exeter NHS Foundation 
Trust, Exeter EX2 5DW, UK. 
Received: 8 January 2020   Accepted: 13 March 2020
References
 1. Adams J, Silverman M, Musa D, Peele P. Recruiting older adults for clinical 
trials. Control Clin Trials. 1997;18(1):14–26.
 2. Bergström J. Percutaneous needle biopsy of skeletal muscle in physi-
ological and clinical research. Scand J Clin Lab Invest. 1975;35(7):609–16.
 3. Clark DJ, Pojednic RM, Reid KF, Patten C, Pasha EP, Phillips EM, Fielding RA. 
Longitudinal decline of neuromuscular activation and power in healthy 
older adults. J Gerontol A Biol Sci Med Sci. 2013;68(11):1419–25.
 4. Health Survey for England. 2016. http://healt hsurv ey.hscic .gov.uk/media 
/63730 /HSE16 -Adult -phy-act.pdf. Accessed 20 May 2019.
 5. House of Commons Science and Technology Committee. 2013. https ://
publi catio ns.parli ament .uk/pa/cm201 314/cmsel ect/cmsct ech/104/10406 
.htm. Accessed 31 Jan 2019.
 6. Huggett DL, Connelly DM, Overend TJ. Maximal aerobic capacity 
testing of older adults: a critical review. J Gerontol A Biol Sci Med Sci. 
2005;60(1):57–66.
 7. Irving BA, Lanza IR, Henderson GC, Rao RR, Spiegelman BM, Nair KS. Com-
bined training enhances skeletal muscle mitochondrial oxidative capacity 
independent of age. J Clin Endocrinol Metab. 2015;100(4):1654–63.
 8. Jessup JV, Horne C, Yarandi H, Quindry J. The effects of endurance 
exercise and vitamin E on oxidative stress in the elderly. Biol Res Nurs. 
2003;5(1):47–55.
 9. Landray MJ, Haynes R, Hopewell JC, Parish S, Aung T, Tomson J, Wal-
lendszus K, Craig M, Jiang L, Collins R, Armitage J. Effects of extended-
release niacin with laropiprant in high-risk patients. N Engl J Med. 
2014;371(3):203–12.
 10. Laukkanen P, Heikkinen E, Kauppinen M. Muscle strength and mobil-
ity as predictors of survival in 75–84-year old people. Age Ageing. 
1995;24(6):468–73.
 11. Lovato LC, Hill K, Hertert S, Hunninghake DB, Probstfield JL. Recruitment 
for controlled clinical trials: literature summary and annotated bibliogra-
phy. Control Clin Trials. 1997;18(4):328–52.
 12. Luukinen H, Koski K, Laippala P, Kivelä SL. Factors predicting fractures dur-
ing falling impacts among home-dwelling older adults. J Am Geriatr Soc. 
1997;45(11):1302–9.
 13. Macias FM, Ramsay RE, Rowan AJ. Recruitment and retention in clinical 
trials of the elderly. Int Rev Neurobiol. 2007;81:265–72.
 14. Marsh GD, Patersin DH, Govindasamy D, Cunningham DA. Anaerobic 
power of the arms and legs of young and older men. Exp Physiol. 
1999;84(3):589–97.
 15. McDonald AM, Knight RC, Campbell MK, Entwistle VA, Grant AM, Cook JA, 
Elbourne DR, Francis D, Garcia J, Roberts I, Snowdon C. What influences 
recruitment to randomised controlled trials? A review of trials funded by 
two UK funding agencies. Trails. 2006;7:7–9.
 16. Mody L, Miller DK, McGloin JM, Freeman M, Marcantonio ER, Magaziner J, 
Studenski S. Recruitment and retention of older adults in aging research. 
J Am Geriatr Soc. 2008;56(12):2340–8.
 17. Niccoli T, Partridge L. Ageing as a risk factor for disease. Curr Biol. 
2012;22(17):R741–52.
 18. Office for National Statistics. Overview of the UK population: July 2017. 
https ://www.ons.gov.uk/peopl epopu latio nandc ommun ity/popul ation 
Page 7 of 7Deane et al. BMC Res Notes          (2020) 13:174  
•
 
fast, convenient online submission
 •
  
thorough peer review by experienced researchers in your field
• 
 
rapid publication on acceptance
• 
 
support for research data, including large and complex data types
•
  
gold Open Access which fosters wider collaboration and increased citations 
 
maximum visibility for your research: over 100M website views per year •
  At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
Ready to submit your research ?  Choose BMC and benefit from: 
andmi grati on/popul ation estim ates/artic les/overv iewof theuk popul ation /
july2 017. Accessed 03 May 2019.
 19. Parker BA, Thompson PD. Effect of statins on skeletal muscle: exercise, 
myopathy and muscle outcomes. Exerc Sport Sci Rev. 2012;40(4):188–94.
 20. Paterson DH, Jones GR, Rice CL. Ageing and physical activity: evidence to 
develop exercise recommendations for older adults. Can J Public Health. 
2007;98(2):S69–108.
 21. Piantadosi C, Chapman IM, Naganathan V, Hunter P, Cameron ID, Visvana-
than R. Recruiting older people at nutritional risk for clinical trials: what 
have we learned? BMC Res Notes. 2015;8(151):1–7.
 22. Ridda I, MacIntyre CR, Lindley RI, Tan TC. Difficulties in recruiting older 
people in clinical trials: an examination of barriers and solutions. Vaccine. 
2010;28(4):901–6.
 23. Taylor D. Physical activity is medicine for older adults. Postgrad Med J. 
2014;90(1059):26–32.
 24. Ueda P, Lung TW, Clarke P, Danaei G. Application of the 2014 NICE choles-
terol guideloines in the English population: a cross-sectional analysis. Br J 
Gen Pract. 2017;67(662):e598–608.
 25. Wang AE, Drayton S, Fraser HE. Delay No More: Improve patient recruit-
ment and reduce time to market in the pharmaceutical industry. Somers 
(NY): IBM Institute for Business Value, IBM Global Business Services. 2003. 
http://www-935.ibm.com/servi ces/us/imc/pdf/g510-3320-00del ay-no-
more-impro ving-patie nt-recru itmen t.pdf. Accessed 31 Jan 2019.
 26. Wilding MJ, Seegert L, Rupcic S, Griffin M, Kachnowski S, Parasuraman S. 
Falling short: recruiting elderly individuals for a fall study. Ageing Res Rev. 
2013;12(2):552–60.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
